ability to work with data analytics platforms (Qlik, Tableau or similar) Experience in biotech-pharma and ideally onco-hematology... precious moment of life. In Oncology, we strive to become a global pharma innovator with competitive advantage, creating novel...
organization ⢠Experience working in Biotech or Pharmaceutical industry ⢠Understanding of SDLC guidelines and supporting... validated systems ⢠Understanding of corporate compliance and government regulations ⢠Experience with the Envision Pharma...
and Pathology product portfolio to academic, biotech and pharma customers in Spain. The role is field-based, and working closely... portfolio to customers in Spain, with a focus on academic esearch, biotech and biopharma customers. Achieve sales growth...
care, we complement the expertise of our Pharma, Biotech, and MedTech clients with a full spectrum of services... collaborate across our North American, European, and Asian offices, and advise 80% of the top 50 MedTech/Biotech companies and 75...
and visiting Hematologist/Oncologist offices. Ideally, the Hematology/Oncology Account Manager will have experience in a Biotech.../Pharma environment. Reporting to the Director, OUS Provider Engagement will: Create a referral physician network...
You are fluent in Spanish & English, report to Belgium. The medical device/pharma/biotech world is your passion and you're able..., production and distribution for companies active in ATMP, Biotech, Medical Devices, In Vitro Diagnostics, Digital Health...
Luke Littler was throwing darts while still in his nappy. On Friday, the teenager could take the final step of a journey that began almost as soon as he could walk. Continue Reading »
The Nifty PSU Bank index concluded the year with a gain of 14.48%. Among the top performers, State Bank of India (SBI) led with a gain of 23%, followed by Indian Bank with a return of 24% Continue Reading »
Several auto stocks that were once soaring have seen their prices plummet by as much as 50% from their 52-week highs. These drops could present unique investment opportunities for savvy investors, but beware the risks. Continue Reading »
Kotak Mahindra Bank's stock has fallen over 4% in a year, contrasting with an 11% rise in Nifty Bank. Despite this, it gained 19% from its 52-week low and is 6% below its all-time high. Analysts are optimistic about its recovery potential in 2025. Continue Reading »
Despite a drop in its global market share to 4.2% in December 2024, India’s stable macroeconomics have kept its equity market buoyant. .The Nifty50 recorded a 9% return for 2024, though its performance in December was weak compared to other Asian markets. Continue Reading »
Kotak Mahindra Bank shares have rallied more than 6% in four sessions. Foreign brokerage firm Citi initiated a positive catalyst watch on Kotak Mahindra Bank shares expecting stability in loan growth and lower compression in net interest margin (NIM) in the third quarter of FY25. Continue Reading »
Stocks to buy: Analysts anticipate volatility influenced by US interest rates and trade policies. A potential 5-10% correction is expected in early 2025, yet stock-specific opportunities arise, including buy ratings for Varun Beverages, Tata Technologies, and Kalpataru Projects International. Continue Reading »
Sigachi Industries stock rose over 2% after CARE Ratings reaffirmed its credit ratings. The company saw a 38.1% increase in Q2FY25 revenue, with a profit after tax jump of 39%. However, the stock remains down 14% over the past year. Continue Reading »
Sebi's investigation into Ketan Parekh uncovered a front-running scheme that generated ₹65.77 crore in unlawful profits. In an interim order, the regulator debarred Parekh and two others from trading and issued show-cause notices to 22 entities involved, allowing them 21 days to respond. Continue Reading »